Stifel Financial’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.03M | Buy |
68,185
+41,241
| +153% | +$720K | ﹤0.01% | 2531 |
|
|
2026
Q1 | $517K | Sell |
26,944
-541
| -2% | -$11.8K | ﹤0.01% | 2864 |
|
|
2025
Q4 | $604K | Sell |
27,485
-11,529
| -30% | -$208K | ﹤0.01% | 2757 |
|
|
2025
Q3 | $474K | Buy |
39,014
+3,485
| +10% | +$47.2K | ﹤0.01% | 2851 |
|
|
2025
Q2 | $662K | Buy |
35,529
+234
| +0.7% | +$4.63K | ﹤0.01% | 2593 |
|
|
2025
Q1 | $676K | Buy |
35,295
+522
| +2% | +$15.3K | ﹤0.01% | 2484 |
|
|
2024
Q4 | $1.25M | Buy |
34,773
+701
| +2% | +$23.7K | ﹤0.01% | 2107 |
|
|
2024
Q3 | $1.44M | Buy |
34,072
+2,160
| +7% | +$91.6K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $1.29M | Buy |
31,912
+8,224
| +35% | +$343K | ﹤0.01% | 2003 |
|
|
2024
Q1 | $839K | Buy |
23,688
+471
| +2% | +$12.6K | ﹤0.01% | 2299 |
|
|
2023
Q4 | $687K | Buy |
+23,217
| New | +$482K | ﹤0.01% | 2388 |
|
|
2022
Q3 | – | Sell |
-5,473
| Closed | -$324K | – | 3383 |
|
|
2022
Q2 | $324K | Sell |
5,473
-34,431
| -86% | -$2.83M | ﹤0.01% | 2711 |
|
|
2022
Q1 | $4.64M | Sell |
39,904
-383
| -1% | -$44.7K | 0.01% | 1096 |
|
|
2021
Q4 | $6.06M | Buy |
40,287
+16,081
| +66% | +$2.17M | 0.01% | 965 |
|
|
2021
Q3 | $2.89M | Buy |
24,206
+1,827
| +8% | +$201K | ﹤0.01% | 1336 |
|
|
2021
Q2 | $2.18M | Sell |
22,379
-292
| -1% | -$26K | ﹤0.01% | 1546 |
|
|
2021
Q1 | $2M | Sell |
22,671
-2,040
| -8% | -$190K | ﹤0.01% | 1515 |
|
|
2020
Q4 | $2.37M | Sell |
24,711
-1,901
| -7% | -$196K | ﹤0.01% | 1288 |
|
|
2020
Q3 | $3.02M | Sell |
26,612
-722
| -3% | -$75.9K | 0.01% | 1002 |
|
|
2020
Q2 | $2.7M | Sell |
27,334
-6,778
| -20% | -$541K | 0.01% | 1010 |
|
|
2020
Q1 | $2.18M | Buy |
34,112
+622
| +2% | +$43.6K | 0.01% | 1003 |
|
|
2019
Q4 | $2M | Sell |
33,490
-3,072
| -8% | -$189K | ﹤0.01% | 1339 |
|
|
2019
Q3 | $2.15M | Sell |
36,562
-1,285
| -3% | -$82K | 0.01% | 1262 |
|
|
2019
Q2 | $2.45M | Buy |
37,847
+3,996
| +12% | +$258K | 0.01% | 1211 |
|
|
2019
Q1 | $2.15M | Buy |
33,851
+19,554
| +137% | +$1.03M | 0.01% | 1197 |
|
|
2018
Q4 | $512K | Buy |
+14,297
| New | +$505K | ﹤0.01% | 1927 |
|
|
2017
Q4 | – | Sell |
-1,475
| Closed | -$10K | – | 2726 |
|
|
2017
Q3 | $10K | Buy |
1,475
+100
| +7% | +$633 | ﹤0.01% | 2574 |
|
|
2017
Q2 | $11K | Sell |
1,375
-125
| -8% | -$1.16K | ﹤0.01% | 2551 |
|
|
2017
Q1 | $18K | Buy |
+1,500
| New | +$32.8K | ﹤0.01% | 2503 |
|
|
2016
Q2 | – | Sell |
-1,143
| Closed | -$99K | – | 2566 |
|
|
2016
Q1 | $99K | Sell |
1,143
-13
| -1% | -$1.14K | ﹤0.01% | 2109 |
|
|
2015
Q4 | $136K | Buy |
1,156
+127
| +12% | +$12.6K | ﹤0.01% | 2192 |
|
|
2015
Q3 | $90K | Sell |
1,029
-44
| -4% | -$5.12K | ﹤0.01% | 2142 |
|
|
2015
Q2 | $116K | Buy |
1,073
+13
| +1% | +$1.62K | ﹤0.01% | 2253 |
|
|
2015
Q1 | $134K | Buy |
+1,060
| New | +$138K | ﹤0.01% | 2171 |
|
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Stifel Financial's TNDM Position: Q2 2026 in Review
Stifel Financial increased its Tandem Diabetes Care (TNDM) stake by 153% in Q2 2026, buying an estimated $720K and bringing the position to 68,185 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2531.
Stifel Financial first reported a position in TNDM in Q1 2015 and has held it in 34 quarters since. The position peaked at $6.06M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Stifel Financial held 68,185 shares of Tandem Diabetes Care worth $1.03M as of Q2 2026.
- Stifel Financial bought 41,241 Tandem Diabetes Care shares in Q2 2026, an estimated $720K.
- Tandem Diabetes Care made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2531 holding.
- Stifel Financial first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 34 quarters since.
- Stifel Financial's Tandem Diabetes Care position peaked at $6.06M in Q4 2021.
- 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.